title: Developmental gene expression in the human fetal pancreas.
abstract: Differential developmental regulation of pancreas-specific genes has not been reported for the human fetal pancreas. We have therefore undertaken a systematic, quantitative analysis of the transcriptional levels of various genes in the human pancreas at different stages of fetal and postnatal development. Using sensitive ribonuclease protection assays, in situ hybridization, and the polymerase chain reaction, our results indicate the following: 1) Transcriptional levels of insulin and amylin remain lower in the fetal than in the adult pancreas, whereas glucagon and somatostatin mRNA levels are consistently greater after 14 wk gestation than postnatally. These results are in agreement with previous immunohistochemical studies of these gene products. 2) The reg gene exhibits a 20-fold increase in mRNA levels after 16 wk gestation. The gene is expressed exclusively in the acinar cells and does not colocalize with insulin. This restricted exocrine expression does not indicate a direct role for the reg gene in islet development. 3) Glucose transporter 2 and glucokinase mRNA are detectable as early as 13 wk gestation and remain low throughout development. Glucose transporter 1 reaches adult transcriptional levels by 18 wk gestation. The early detection of glucose transporter 2 and glucokinase implies that lack of expression of these "glucose sensor" genes does not account for the known insensitivity of the fetal beta-cells to glucose.
authors.affiliation: Lucy Thorne Whittier Children's Center, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.
authors.forename: M I
authors.initials: MI
authors.lastname: Mally
authors.forename: T
authors.initials: T
authors.lastname: Otonkoski
authors.forename: A D
authors.initials: AD
authors.lastname: Lopez
authors.forename: A
authors.initials: A
authors.lastname: Hayek
mesh_terms: D000328:Adult; D000591:Amino Acid Isomerases / Q000096:biosynthesis; D000681:Amylases / Q000096:biosynthesis; D000682:Amyloid / Q000096:biosynthesis; D016375:Antisense Elements (Genetics); D002352:Carrier Proteins / Q000096:biosynthesis; D018833:Chaperonins / Q000096:biosynthesis; D003001:Cloning, Molecular; D005333:Fetus; D015870:Gene Expression; D005865:Gestational Age; D005934:Glucagon / Q000096:biosynthesis; D051272:Glucose Transporter Type 1; D006801:Humans; D007223:Infant; D007328:Insulin / Q000096:biosynthesis; D058228:Islet Amyloid Polypeptide; D009004:Monosaccharide Transport Proteins / Q000096:biosynthesis; D010179:Pancreas / Q000196:embryology / Q000378:metabolism*; D019696:Peptidylprolyl Isomerase; D013004:Somatostatin / Q000096:biosynthesis; D014158:Transcription, Genetic
chemical_list: D000682:Amyloid; D016375:Antisense Elements (Genetics); D002352:Carrier Proteins; D051272:Glucose Transporter Type 1; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D009004:Monosaccharide Transport Proteins; C495677:SLC2A1 protein, human; D013004:Somatostatin; D005934:Glucagon; D000681:Amylases; D018833:Chaperonins; D000591:Amino Acid Isomerases; D019696:Peptidylprolyl Isomerase